Complete Filing Data
NIKA PHARMACEUTICALS, INC reported Stockholders Equity of -$297.6 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NIKA PHARMACEUTICALS, INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$76.4K | -$95.8K | -$64.8K | -$3.2M | -$14.7K | -$8.9K |
| Operating Income Loss | -$76.4K | -$95.8K | -$64.8K | -$3.2M | -$14.7K | -$8.9K |
| Operating Expenses | $76.4K | $95.8K | $64.8K | $3.2M | $14.7K | $8.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$76.4K | -$95.8K | -$64.8K | -$3.2M | -$14.7K | -$8.9K |
| General And Administrative Expense | $53.0K | $35.2K | $64.8K | $33.7K | $14.7K | $8.9K |
| Comprehensive Income Net Of Tax | ||||||
| Revenues |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.0K | -$18.4K | -$12.9K | -$8.4K | -$22.5K | -$46.0K | -$10.1K | -$10.1K | -$19.6K | -$6.3K | -$3.2M | -$6.3K | $2.7K | $3.0K | $5.8K | -$160.00 |
| Operating Income Loss | -$8.0K | -$18.4K | -$12.9K | -$8.4K | -$22.5K | -$46.0K | -$10.1K | -$10.1K | -$19.6K | -$6.3K | -$3.2M | $6.3K | -$2.7K | -$3.0K | -$5.8K | -$160.00 |
| Operating Expenses | $8.0K | $18.4K | $12.9K | $8.4K | $22.5K | $46.0K | $10.1K | $10.1K | $19.6K | $6.3K | $3.2M | $6.3K | $2.7K | $3.0K | $5.8K | $160.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.0K | -$18.4K | -$12.9K | -$8.4K | -$22.5K | -$46.0K | -$10.1K | -$10.1K | -$19.6K | -$6.3K | -$3.2M | $6.3K | $2.7K | -$3.0K | -$5.8K | -$160.00 |
| General And Administrative Expense | $3.9K | $14.3K | $1.8K | $6.3K | $7.5K | $8.5K | $10.1K | $10.1K | $19.6K | $6.3K | $6.0K | $6.3K | $2.7K | $3.0K | $5.8K | $160.00 |
| Comprehensive Income Net Of Tax | -$8.0K | -$18.4K | -$12.9K | -$8.4K | -$22.5K | -$46.0K | -$10.1K | |||||||||
| Revenues | $156.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$297.6K | -$221.2K | -$82.1K | -$17.3K | -$23.6K | -$8.9K | |
| Cash And Cash Equivalents At Carrying Value | $1.9K | $2.1K | $19.6K | $864.00 | $1.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.9K | $2.1K | $19.6K | $864.00 | $399.00 | ||
| Retained Earnings Accumulated Deficit | -$9.0M | -$8.9M | -$3.4M | -$3.3M | $151.7K | $137.0K | -$128.1K |
| Common Stock Value | $104.8K | $102.2K | $87.6K | $87.6K | $39.6K | $13.2K | $13.2K |
| Liabilities And Stockholders Equity | $21.0K | $17.9K | $19.6K | $864.00 | $399.00 | $1.6K | |
| Assets Current | $21.0K | $17.9K | $19.6K | $864.00 | $399.00 | $1.6K | |
| Assets | $21.0K | $17.9K | $19.6K | $864.00 | $399.00 | $1.6K | |
| Liabilities | $318.6K | $239.2K | $101.7K | $18.2K | $24.0K | $10.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$194.00 | -$17.5K | $18.7K | $465.00 | -$1.2K | $1.6K | |
| Liabilities Current | $318.6K | $239.2K | $101.7K | $18.2K | $10.5K | ||
| Preferred Stock Value | $1.5K | $1.5K | $1.0K | $1.0K | |||
| Business Combination Consideration Transferred Equity Interests Issued And Issuable | $43.3K | ||||||
| Preferred Stock Value Outstanding | $0.00 | ||||||
| Debt Current | $101.7K | $18.2K | |||||
| Stock And Warrants Issued During Period Value Preferred Stock And Warrants | $3.0M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | |||||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $3.0M | ||||||
| Prepaid Expense And Other Assets | |||||||
| Inventory Net | |||||||
| Cash | $1.9K | $2.1K | $19.6K | $864.00 | $1.6K | ||
| Accounts Payable And Accrued Liabilities Current | |||||||
| Property Plant And Equipment Other Net | |||||||
| Property Plant And Equipment Net | |||||||
| Other Receivables Net Current | |||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.2K | $1.6K | |||||
| Accounts Receivable Net Current | |||||||
| Accounts Payable Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$260.5K | -$252.6K | -$234.2K | -$200.4K | -$208.8K | -$224.5K | -$74.8K | -$64.7K | -$36.9K | -$2.3K | $4.1K | $83.00 | -$20.3K | -$17.6K | -$14.7K | -$160.00 | |||
| Cash And Cash Equivalents At Carrying Value | $6.3K | $15.6K | $19.1K | $1.4K | $7.5K | $24.5K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | $83.00 | $399.00 | $1.7K | $398.00 | $1.4K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.3K | $15.6K | $19.1K | $1.4K | $4.8K | $19.6K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | ||||||||
| Retained Earnings Accumulated Deficit | -$9.0M | -$9.0M | -$8.9M | -$8.9M | -$9.0M | -$9.0M | -$3.4M | -$3.4M | -$3.4M | $3.3M | $414.0K | $158.0K | -$148.4K | -$145.7K | $142.7K | ||||
| Common Stock Value | $104.0K | $102.6K | $102.6K | $101.9K | $101.9K | $87.6K | $87.6K | $87.6K | $87.6K | $87.6K | $87.6K | $13.2K | $13.2K | $13.2K | $13.2K | ||||
| Liabilities And Stockholders Equity | $23.6K | $31.6K | $35.0K | $1.4K | $390.3K | $41.5K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | $83.00 | $1.7K | $398.00 | $1.4K | ||||
| Assets Current | $23.6K | $31.6K | $35.0K | $1.4K | $222.1K | $41.5K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | $83.00 | $1.7K | $398.00 | $1.4K | ||||
| Assets | $23.6K | $31.6K | $35.0K | $1.4K | $390.3K | $41.5K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | $83.00 | $1.7K | $398.00 | $1.4K | ||||
| Liabilities | $284.2K | $284.2K | $269.2K | $210.2K | $636.9K | $266.0K | $85.7K | $75.7K | $41.3K | $6.2K | $4.5K | $22.0K | $18.0K | $16.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $17.1K | $14.7K | $3.6K | -$316.00 | -$254.00 | ||||||||||||||
| Liabilities Current | $284.2K | $284.2K | $269.2K | $210.2K | $636.9K | $266.0K | $85.7K | $75.7K | $41.3K | $6.2K | $4.5K | ||||||||
| Preferred Stock Value | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.0K | $1.0K | $1.0K | $1.0K | $10.0K | $10.0K | ||||||||
| Business Combination Consideration Transferred Equity Interests Issued And Issuable | $43.5K | $76.3K | |||||||||||||||||
| Preferred Stock Value Outstanding | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Debt Current | $85.7K | $75.7K | $41.3K | ||||||||||||||||
| Stock And Warrants Issued During Period Value Preferred Stock And Warrants | |||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.7K | $398.00 | $1.4K | $1.6K | |||||||||||||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $3.0M | ||||||||||||||||||
| Prepaid Expense And Other Assets | $17.3K | $16.0K | $15.9K | $15.9K | |||||||||||||||
| Inventory Net | $14.1K | $17.0K | |||||||||||||||||
| Cash | $6.3K | $15.6K | $19.1K | $1.4K | $7.5K | $24.5K | $10.9K | $11.1K | $4.5K | $3.9K | $8.5K | $83.00 | $399.00 | $1.7K | $398.00 | $1.4K | |||
| Accounts Payable And Accrued Liabilities Current | $4.6K | $9.3K | |||||||||||||||||
| Property Plant And Equipment Other Net | $168.3K | ||||||||||||||||||
| Property Plant And Equipment Net | $168.3K | ||||||||||||||||||
| Other Receivables Net Current | $4.1K | ||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | |||||||||||||||||||
| Accounts Receivable Net Current | $196.4K | ||||||||||||||||||
| Accounts Payable Current | $1.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Related Party Debt | $79.5K | $137.4K | $83.6K | $24.2K | $13.5K | $10.5K |
| Net Cash Provided By Used In Operating Activities | -$79.7K | -$154.9K | -$64.8K | $33.7K | $14.7K | -$8.9K |
| Net Cash Provided By Used In Financing Activities | $79.5K | $137.4K | $83.6K | $34.2K | $13.5K | $10.5K |
| Proceeds From Issuance Of Common Stock | $10.0K | |||||
| Increase Decrease In Prepaid Expense | $3.3K | $15.9K | ||||
| Increase Decrease In Inventories | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Proceeds From Related Party Debt | $30.0K | $99.0K | $23.2K | $6.0K | $5.5K |
| Net Cash Provided By Used In Operating Activities | -$12.9K | -$84.3K | -$19.6K | -$6.3K | -$5.8K |
| Net Cash Provided By Used In Financing Activities | $30.0K | $99.0K | $23.2K | $6.0K | $5.5K |
| Proceeds From Issuance Of Common Stock | |||||
| Increase Decrease In Prepaid Expense | |||||
| Increase Decrease In Inventories | $17.0K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $9.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 1.05B | 1.02B | 876.1M | 724.0M | 396.1M | ||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 1.05B | 1.05B | 876.1M | 876.1M | 396.1M | 13.2M | 13.2M |
| Common Stock Shares Authorized | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 90.0M | 90.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.05B | 1.02B | 876.1M | 724.0M | 396.1M | ||
| Preferred Stock Shares Issued | 15.0M | 15.0M | 10.0M | 10.0M | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Issued | 1.05B | 1.05B | 876.1M | 876.1M | 13.2M | 13.2M | |
| Preferred Stock Shares Outstanding | 15.0M | 15.0M | 10.0M | 10.0M | 0.00 | 0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.2M | 13.2M | 13.2M | ||||
| Stock Issued During Period Shares Issued For Services |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 1.03B | 1.03B | 1.02B | 876.1M | 876.1M | 876.1M | 876.1M | 740.6M | 740.6M | 396.1M | 396.1M | 396.1M | 13.2M | ||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 1.04B | 1.03B | 1.03B | 1.02B | 1.02B | 876.1M | 876.1M | 876.1M | 876.1M | 876.1M | 13.2M | 13.2M | 13.2M | 13.2M | |||||
| Common Stock Shares Authorized | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 2.70B | 90.0M | 90.0M | 90.0M | 90.0M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.04B | 1.03B | 1.03B | 1.02B | 1.02B | 876.1M | 876.1M | 876.1M | 740.6M | 740.6M | 13.2M | 396.1M | 396.1M | 13.2M | |||||
| Preferred Stock Shares Issued | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Common Stock Shares Issued | 1.04B | 1.03B | 1.03B | 1.02B | 1.02B | 876.1M | 876.1M | 876.1M | 876.1M | 876.1M | 876.1M | 13.2M | 396.1M | 13.2M | 13.2M | 13.2M | |||
| Preferred Stock Shares Outstanding | 15.0M | 15.0M | 10.0M | 15.0M | 15.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.2M | 13.2M | 13.2M | 13.2M | 13.2M | 13.2M | |||||||||||||
| Stock Issued During Period Shares Issued For Services | 150.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $8.6M | $8.6M | $3.2M | $3.2M | $88.5K | $114.9K | $114.9K |
| Professional Fees | $23.4K | $60.6K | |||||
| Short Term Borrowings | $318.6K | $239.2K | $101.7K | ||||
| Due To Related Parties Noncurrent | $13.5K | $10.5K | |||||
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | $30.0K | ||||||
| Stock Issued During Period Value Issued For Services | $150.0K | ||||||
| Due To Related Parties Current | $18.2K | $10.5K | |||||
| Business Development | $3.0M | ||||||
| Business Combination Acquisition Related Costs | $150.0K | ||||||
| Noncash Merger Related Costs | $43.3K | ||||||
| Stock Issued During Period Value New Issues | $10.0K | ||||||
| Stock Issued During Period Shares Other | |||||||
| Stock Issued During Period Shares New Issues | |||||||
| Prepaid Expense Current | $19.1K | $15.9K | |||||
| Adjustments To Additional Paid In Capital Other |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $3.2M | $3.2M | $3.2M | $3.2M | $320.5K | $144.9K | $114.9K | $114.9K | $114.9K |
| Professional Fees | $4.1K | $4.1K | $11.1K | $2.1K | $15.0K | $37.5K | $6.8K | ||||||||
| Short Term Borrowings | $284.2K | $284.2K | $269.2K | $210.2K | $632.3K | $256.6K | |||||||||
| Due To Related Parties Noncurrent | $22.0K | $18.0K | $16.0K | ||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | $30.0K | ||||||||||||||
| Stock Issued During Period Value Issued For Services | $150.0K | ||||||||||||||
| Due To Related Parties Current | $6.2K | $3.0K | |||||||||||||
| Business Development | $3.0M | ||||||||||||||
| Business Combination Acquisition Related Costs | $150.0K | ||||||||||||||
| Noncash Merger Related Costs | $38.4K | ||||||||||||||
| Stock Issued During Period Value New Issues | $10.0K | ||||||||||||||
| Stock Issued During Period Shares Other | 5.0M | ||||||||||||||
| Stock Issued During Period Shares New Issues | 30.0M | ||||||||||||||
| Prepaid Expense Current | |||||||||||||||
| Adjustments To Additional Paid In Capital Other | $30.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.